Associate Professor, Medicine, Weill Cornell Med College
Rheumatology
Dr. Vivian P. Bykerk, MD
|
|
Give Review
Vivian Bykerk practices Rheumatology. She has 1 awards "Fellow". Dr. Vivian P. Bykerk has written publications. She has 73 publications published with PubMed. The lastest paper is: 'Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled t...' She is registered with Medicare and accepts Medicare payments.
Publications
- Improvements in Patient-Reported outcomes Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe,...
- Improvements in Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients w...
- Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid Arthritis and inadequate responses to previou...
- Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary.
- Outcomes related to methotrexate dose and route of administration in patients with rheumatoid Arthritis: a systematic literature review.
- Detecting the Earliest Signs of Rheumatoid Arthritis: Symptoms and Examination.
- Preclinical rheumatic Disease.
- Does Socioeconomic Status Affect Outcomes in Early Inflammatory Arthritis? Data from a Canadian Multisite Suspected Rheumatoid Arthritis Inception Cohort.
- Earlier Time to Remission Predicts Sustained Clinical Remission in Early Rheumatoid Arthritis - Results from the Canadian Early Arthritis Cohort (CATCH).
- Effect of age at menopause on disease presentation in early rheumatoid Arthritis: Results from the Canadian Early Arthritis Cohort.
- Establishing a Core Domain Set to Measure Rheumatoid Arthritis Flares: Report of the OMERACT 11 RA Flare Workshop.
- Flares in Rheumatoid Arthritis: Frequency and Management. A Report from the BRASS Registry.
- Update on the safety profile of certolizumab pegol in rheumatoid Arthritis: an integrated analysis from clinical trials.
- Determining Best Practices in Early Rheumatoid Arthritis by Comparing Differences in Treatment at Sites in the Canadian Early Arthritis Cohort.
- Imaging of rheumatoid Arthritis.
- Incidence and predictors of secondary fibromyalgia in an early Arthritis cohort.
- Treatment strategies for early rheumatoid Arthritis.
- Achieving remission in clinical practice: lessons from clinical trial data.
- Validation of a Self-administered Inflammatory Arthritis Detection Tool for Rheumatology Triage.
- The new ACR/EULAR remission criteria: rationale for developing new criteria for remission.
- The new ACR/EULAR classification criteria for RA: how are the new criteria performing in the clinic?
- Tocilizumab in patients with active rheumatoid Arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice.
- Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory Arthritis: results from the CATCH cohort.
- Remission and radiographic outcome in rheumatoid Arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.
- Safety and Effectiveness of Rituximab in Patients with Rheumatoid Arthritis Following an Inadequate Response to 1 Prior Tumor Necrosis Factor Inhibitor: The RESET Trial.
- Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic ...
- Emerging Issues in Pharmacological Management of Rheumatoid Arthritis: Results of a National Needs Assessment Survey Identifying Practice Variations for the Developmen...
- Early Management of Newly Diagnosed Rheumatoid Arthritis by Canadian Rheumatologists: A National, Multicenter, Retrospective Cohort.
- Canadian Recommendations for Clinical Trials of Pharmacologic Interventions in Rheumatoid Arthritis: Inclusion Criteria and Study Design.
- Rheumatoid Arthritis: 2011 remission criteria are a new benchmark for RA therapy.
- Strategies to prevent rheumatoid Arthritis in high-risk patients.
- Classification of rheumatologic opinion on early inflammatory Arthritis: harmonization of a heterogeneous standard.
- 2010 Rheumatoid Arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
- Rheumatoid Arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population.
- Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory Arthritis: integrating systematic literature ...
- Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid Arthritis: a meta-analysis of clinical and radiogra...
- Validation of a prediction rule for development of rheumatoid Arthritis in patients with early undifferentiated Arthritis.
- Distinctive gene expression signatures in rheumatoid Arthritis synovial tissue fibroblast cells: correlates with disease activity.
- Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid Arthritis. Results of a multicenter randomized, double-blind, placebo-controlled t...
- Systemic vasculitis following influenza vaccination--report of 3 cases and literature review.
- Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial.
- The seal finger: an unusual case of monoarticular sepsis.
- Role of infliximab in the treatment of early rheumatoid Arthritis.
- Role of adalimumab in the treatment of early rheumatoid Arthritis.
- What are the goals and principles of management in the early treatment of rheumatoid Arthritis?
- Adalimumab for early rheumatoid Arthritis.
- All that glitters is not gold--standardizing diagnosis in rheumatoid Arthritis studies.
- Utility and feasibility of musculoskeletal ultrasonography (MSK US) in rheumatology practice in Canada: needs assessment.
- The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid Arthritis: methodological report phase I.
- Delay in receiving rheumatology care leads to long-term harm.
- Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory Arthritis: a systematic literature review.
- Fibrocyte activation in rheumatoid Arthritis.
- Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid Arthritis: implications for diagnosis and monitoring drug therapy.
- Anti-cyclic citrullinated peptide antibody versus HAQ/MDHAQ: comparing apples and oranges?
- Unmet needs in rheumatoid Arthritis.
- CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid Arthritis and primary biliary cirrhosis in the Canadian population.
- Smoldering rheumatoid Arthritis: is the Canadian healthcare system neglecting a significant disease population?
- Etanercept in the treatment of rheumatoid Arthritis.
- Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the Shoulder: a placebo-controlled trial.
- Infusion-related reactions to infliximab in patients with rheumatoid Arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and in...
- Rheumatoid Arthritis: is the disease becoming milder or is treatment improving?
- Are the 2002 American College of Rheumatology guidelines for the management of rheumatoid Arthritis being followed in Canada''s largest academic rheumatology center?
- Development of a self-administered early inflammatory Arthritis detection tool.
- When does rheumatoid Arthritis start and can it be stopped before it does?
- Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid Arthritis: a systematic literature search on 5 ca...
- Access to care for rheumatology patients may be compromised: results of a survey to members of the Canadian Rheumatology Association.
- Canadian recommendations for use of methotrexate in patients with rheumatoid Arthritis.
- Care gap in patients with early inflammatory Arthritis with a high fracture risk identified using FRAX(®).
- 2010 rheumatoid Arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
- The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid Arthritis: Phase 2 methodological report.
- Algorithm for identification of undifferentiated peripheral inflammatory Arthritis: a multinational collaboration through the 3e initiative.
- Identifying preliminary domains to detect and measure rheumatoid Arthritis flares: report of the OMERACT 10 RA Flare Workshop.
Procedures Preformed
- Joint Drainage
- Steroid Injection
- Trigger Point Injection
Conditions Treated
- Ankylosing Spondylitis
- Arthritis
- Bursitis
- Carpal Tunnel Syndrome
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- Fellow
Hospital
-
Hospital for Special Surgery -
NewYork-Presbyterian/Weill Cornell
Drug Facts
| NPI NUMBER | 1497089502 | |
| NPPES Provider LastName | BYKERK | |
| NPPES Provider FirstName | VIVIAN | |
| NPPES Provider ZIPCode | 100214823 | |
| NPPES Provider State | NY | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 156.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497089502 |
| Last Name Of The Provider | BYKERK |
| First Name Of The Provider | VIVIAN |
| View All |
Similar Doctors
|
|
Dr. Susan Y. Ritter, MD |
|
|
Dr. Janice Lin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul A. Monach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. K F. Austen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. William F. Harvey, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Senada Arabelovic, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Burton Sack, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ari J. Schwartz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grace H. Lo, MD |
|
|
Dr. Amy M. Wasserman, MD
This Doctor is OpenDoctor Recommended.
|